Study number 8539-034
Dates
Aug 10 2025-Nov 03 2025
Location
Dallas, Texas
Age
18-65
Gender
Both Males and Females
Smoker
No
Compensation
$12,736
Group
Pt A 7a & 7b
The investigational drug in this research study is being developed for the treatment of vitiligo, a disease that causes loss of skin color in patches, and related autoimmune disorders. This is the first time that this study drug is being given to humans.
Fortrea Dallas, Tx is recruiting for:
-Healthy Men and Women, age 18-65
-Body Mass Index between 18-32
-Study involves 1 stay of 7 nights & 8 follow-up visits
-Compensation up to $12,736 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
*Females must be of nonchildbearing potential
Pt A C7a:
Check-in: Aug 10
Check-out: Aug 17
Follow-up: Aug 20, 25, Sep 1, 8, 22, Oct 6, 20, Nov 3
OR
Pt A C7b:
Check-in: Aug 11
Check-out: Aug 18
Follow-up: Aug 21, 26, Sep 2, 9, 23, Oct 7, 21, Nov 4